Isn't the former chairman of Hengrui be fined 950,000?Netizen: Too ruthless, a breakfast money is gone!

Isn't the former chairman of Hengrui be fined 950,000? Netizen: Too ruthless, a breakfast money is gone!

Source: Yaozhi.com/fennel

Zhou Yunshu, former chairman of Hengrui, was on the stall.

On September 19, the Heilongjiang Securities Regulatory Bureau issued an announcement that Zhou Yunshu, former chairman and general manager of Hengrui Pharmaceutical, was affected by insider transactions, which was "no penalty", that is, 450,000 yuan in illegal income and a fine of 500,000 yuan. The total penalty was 950,000 yuan.

Picture source: Heilongjiang Securities Regulatory Bureau official website

Borrowing classmate account transaction

It is worth noting that Zhou Yunshu's insider trading is not his own stock, but Sitai Pharmaceutical, who is a peer. The timeline is 2020. At the time of Zhou Yunshu, he was the chairman, general manager, and director of Hengrui Pharmaceutical.

According to the announcement of the Heilongjiang Securities Regulatory Bureau, in February 2020, the president of Sitai Lou and Shen Mou, the deputy general manager of Hengrui Medicine, said that Steo's iodine alcohol injection and iodone injection will be obtained in the near future. The pharmaceutical regulatory bureau was approved, and Sitai did not have a sales team. Shen Mouping said that he could help Sitai's sales of domestic reagents through Hengrui Pharmaceutical.

Since then, Shen Mou Ping reported to Zhou Yunshu's exclusive agent of Hengrui Pharmaceutical's exclusive agent.

On April 27, Shen Mouping and Zhou Yunshu's telephone communication contract clause. Zhou Yunshu believed that the contract was not big and advanced as soon as possible.

On May 11, Sitai and wholly -owned subsidiaries signed a cooperation agreement with Hengrui Pharmaceutical; on May 13, Sitai and Hengrui Medicine both announced the cooperation agreement.

From April 29th to May 11th, Zhou Yunshu took the account of "Liu Mou", a classmate "Liu Mou" who worked in the insurance financial branch of Hengrui Medical Finance Department. Essence

On May 13, Zhou Yunshu sold all, with a total profit of 450,000 yuan.

According to the announcement, the Heilongjiang Regulatory Bureau conducted a case investigation and trial on the "Sitai" stock behavior of Zhou Yunshu's insider trading, and told the parties to hold a hearing process and other processes. The investigation and trial have ended in this case.

Zhou Yunshu, who is it?

Maybe many people know the "medicine god" Sun Fansheng, but do not understand Zhou Yunshu.

According to relevant information, Zhou Yunshu served as chairman and general manager of Hengrui from January 16, 2020 to July 9, 2021.

Prior to this, Zhou Yunshu had performed his duties for 17 years in the post of general manager.

Hengrui Pharmaceutical Announcement shows that Zhou Yunshu graduated from China Pharmaceutical University in 1995 and worked at Jiangsu Hengrui Pharmaceutical Co., Ltd. since 1995. He has served as deputy minister, deputy general manager, general manager, and director of the Ministry of Development.

Zhou Yunshu has the "Old Hengrui". Like most of Hengrui executives, he also joined Hengrui Pharmaceutical from college and participated in and witnessed the step -by -step transformation of Hengrui Pharmaceutical.

In fact, Zhou Yunshu, who took office, did not bring too many changes to Hengrui Medicine. Less than two years of taking office, Hengrui Pharmaceutical from the highest point of 97.23 yuan/share from the highest point in 2021, with a market value of 600 billion yuan, to 200 billion Around the yuan, it evaporated nearly 400 billion yuan.

The market value of Hengrui Pharmaceuticals changes

Yaizhi.com

In July 2021, Hengrui Pharmaceutical announced that the chairman and general manager Mr. Zhou Yunshu resigned from the company's chairman and general manager for physical reasons, and Sun Piaogao came out again.

Netizens exploded the pot

The profit is 450,000 and the fine is 500,000, which makes some netizens calm down.

On the one hand, netizens believe that insider transactions are not desirable, resolutely support relevant national policies, and standardize securities market transactions, which will help the long -term development of various industries.

On the other hand, netizens believe that the fine of this is lighter, and "a breakfast is gone."

↓↓↓

Netizens leave a message

Picture source: Medical representative public account

What do you think of it? Welcome to leave a message to discuss ~

Reference source:

1.E medicine fast news: Zhou Yunshu, the new chairman of Hengrui Pharmaceutical, who is also?

2. Siqi Club: The former chairman was fined 950,000 yuan, Hengrui's latest response

3. Medical Representative: The former chairman of Hengrui was fined 950,000! The reason is……

- END -